Katy Burris, MD, FAAD
SESSIONS
F082 The Metabolic Revolution: Training Dermatologists to be Prepared for/Incorporate/Utilize GLP-1 Agonists and Other Antidiabetics in Skin Disease
Mar 10, 2025
•
9:00 AM - 11:00 AM
•
W315A
DISCLOSURES
Bristol Myers Squibb – Advisory Board(Honoraria); EBSCO Industries, Inc. – Independent Contractor(Fees);